Compare BC & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BC | CAI |
|---|---|---|
| Founded | 1845 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Homebuilding | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 6.2B |
| IPO Year | 1994 | 2025 |
| Metric | BC | CAI |
|---|---|---|
| Price | $74.45 | $24.80 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $83.55 | $30.91 |
| AVG Volume (30 Days) | 612.6K | ★ 5.3M |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.22% | N/A |
| EPS Growth | N/A | ★ 69.79 |
| EPS | ★ 1.99 | N/A |
| Revenue | ★ $5,362,800,000.00 | $812,033,000.00 |
| Revenue This Year | $9.81 | $25.24 |
| Revenue Next Year | $5.11 | $22.32 |
| P/E Ratio | $36.87 | ★ N/A |
| Revenue Growth | 2.40 | ★ 96.97 |
| 52 Week Low | $58.66 | $14.19 |
| 52 Week High | $90.25 | $36.79 |
| Indicator | BC | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 35.04 | 59.26 |
| Support Level | $73.94 | $17.15 |
| Resistance Level | $76.55 | $28.88 |
| Average True Range (ATR) | 2.27 | 1.37 |
| MACD | -0.81 | -0.14 |
| Stochastic Oscillator | 15.82 | 50.00 |
Brunswick is a leading manufacturer in the marine recreation industry. The firm has more than 60 brands delivering products across propulsion (outboard, sterndrive, and inboard engines, propulsion-related controls, rigging, and propellers), parts, accessories, and technology, and boats (including well-known brands like Boston Whaler and Sea Ray). It also owns more than 450 Freedom Boat Club locations as well as Boateka, which facilitates transactions in the used-boat market. Brunswick's focus surrounds building the innovative marine and recreational experiences, technologies, and connections supported by quality and innovation.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.